India Government Plans Overhaul of Tax Administration for Smooth GST Rollout Exclusive Smart Glasses Market Surge Pressures Traditional Eyewear Leaders Kevin Warsh Faces Potential Policy Challenges as Fed Grapples with Inflation and Rising Yields Quantum Computing Stocks Surge on US Governments 2 Billion Funding Plan and Equity Stakes Homeowners Urged to Compare HELOC and Home Equity Loan Rates Despite Low Market Averages Jim Cramer Expresses Admiration for Target TGT After Recent Performance Wheaton Precious Metals WPM Q1 2026 Earnings Earnings Beat Expectations Shares Dip Slightly Grifols Q4 2025 Earnings EPS Surpasses Estimates by 104 Amid Mixed Market Reaction AZZ Q1 2026 Earnings Earnings Beat Drives Narrow Stock Move DSX Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines FLR Q1 2026 Earnings EPS Falls 775 Short of Estimates Stock Gains 077 Grupo Aeromexico Q4 2025 Earnings EPS Falls Sharply Short of Estimates as Operational Headwinds Persist Investar Holding ISTR Slips 048 Support Holds as Stock Consolidates Near Midpoint Nuveen Core Equity Alpha Fund JCE Holds Steady Near Resistance as Volume Patterns Suggest Caution Adial Pharmaceuticals ADIL Surges 769 Breaking Above Key Support Perimeter Solutions SA PRM Edges Higher on Modest Gains as Shares Test Key Moving Averages Ferrari RACE Shares Dip Nearly 6 as Luxury Sector Faces Headwinds Trumps Grip on a Shrinking Republican Party Implications for Political Stability and Markets QCRH Q1 2026 Earnings EPS Beats Estimates by 85 Stock Slightly Lower BRC Group Senior Notes RILYN Hold Firm at 2486 as Bond Market Sentiment Stabilizes STEX Q1 2026 Earnings Significant EPS Miss as Streamex Corp Reports WiderThanExpected Loss BUSE Q1 2026 Earnings EPS Beat by 132 with Strong Core Performance AbCellera Biologics ABCL Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher PTON Q1 2026 Earnings EPS Miss Masks Optimism Stock Surges 1023 APH Q1 2026 Earnings EPS Surges 1127 Above Estimates DLR Q1 2026 Earnings Slight EPS Beat Amid Data Center Demand NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase